Literature DB >> 7116356

Failure of 5-day vinblastine infusion in the treatment of patients with advanced refractory breast cancer.

I Tannock, C Erlichman, D Perrault, I Quirt, M King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7116356

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Phase II study of divided-dose vinblastine in advanced breast cancer patients.

Authors:  G Giaccone; M Bagatella; O Bertetto; M Donadio; A Calciati
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancer.

Authors:  L Kayitalire; F Thomas; T Le Chevalier; C Toussaint; T Tursz; M Spielmann
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

Review 4.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.